Oct. 04--AMMAN -- HRH Princess Ghida Talal, the chairperson of the King Hussein Cancer Foundation's board of trustees, on Tuesday signed a memorandum of understanding (MoU) with the CEO of Novartis Pharma AG, Bruno Strigini, the Jordanian News Agency, Petra, reported.
The memorandum aims at enhancing cooperation between the two corporations in scientific research."Research is considered a vital and integrated part at [KHCC] to improve the diagnostic and treatment process of cancer patients, which is in-line with the centre's efforts that is aimed towards saving our patients," Princess Ghida said.
The memorandum was signed in the presence of Asem Mansour, director general of KHCC and Hekmat Abdul Razzaq, deputy director general of KHCC.
(c)2017 the Jordan Times (Amman, Jordan)
Visit the Jordan Times (Amman, Jordan) at www.jordantimes.com
Distributed by Tribune Content Agency, LLC.
© Tribune Content Agency, source Regional News